XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.23.3

STOCKHOLDERS’ EQUITY (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2023
Equity [Abstract] |
SCHEDULE OF STOCK WARRANT ACTIVITY | Warrant detail for the three months ended September 30, 2023 is reflected below: SCHEDULE OF STOCK WARRANT ACTIVITY
|  | Number of Warrants |  |  | Weighted Average Exercise Price Per Warrant |  |  | Weighted Average Remaining Contract Term (# years) |
Warrants outstanding and exercisable at June 30, 2023 |  |  | 1,455,119 |  |  | $ | 6.10 |  |  |  |  |
Warrants issued |  |  |  |  |  |  |  |  |  |  |  |
Weighted Average Exercise Price,Warrants issued |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  | - |  |  |  |  |  |  |  |  |
Warrants exercised |  |  | (83,205 | ) |  | $ | 4.00 |  |  |  |  |
Warrants outstanding and exercisable at September 30, 2023 |  |  | 1,371,914 |  |  | $ | 6.23 |  |  |  | 3.18 |
Warrant detail for the three months ended September 30, 2022 is reflected below:
|  | Number of Warrants |  |  | Weighted Average Exercise Price Per Warrant |  |  | Weighted Average Remaining Contract Term (# years) |
Warrants outstanding and exercisable at June 30, 2022 |  |  | 1,455,119 |  |  | $ | 4.496.10 |  |  |  |  |
Warrants issued |  |  | - |  |  | $ | - |  |  |  |  |
Warrants exercised |  |  | - |  |  |  |  |  |  |  |  |
Warrants outstanding and exercisable at September 30, 2022 |  |  | 1,455,119 |  |  | $ | 6.10 |  |  |  | 3.98 |
SCHEDULE OF STOCK OPTIONS ACTIVITY | Activity in the Company’s stock options during the three months ended September 30, 2023 and related balances outstanding as of that date are reflected below: SCHEDULE OF STOCK OPTIONS ACTIVITY
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contract Term (# years) |
Outstanding at June 30, 2023 |  |  | 969,434 |  |  | $ | 6.45 |  |  |  |  |
Granted |  |  | - |  |  | $ | - |  |  |  |  |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |
Forfeited and cancelled |  |  | (30,264 | ) |  | $ | 8.19 |  |  |  |  |
Outstanding at September 30, 2023 |  |  | 939,170 |  |  | $ | 6.40 |  |  |  | 7.29 |
Exercisable at September 30, 2023 |  |  | 376,978 |  |  | $ | 10.82 |  |  |  | 4.62 |
Activity in the Company’s stock options during the three months ended September 30, 2022 and related balances outstanding as of that date are reflected below:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contract Term (# years) |
Outstanding at June 30, 2022 |  |  | 503,433 |  |  | $ | 11.03 |  |  |  |  |
Granted |  |  | - |  |  | $ | - |  |  |  |  |
Exercised |  |  | - |  |  | $ | - |  |  |  |  |
Forfeited and cancelled |  |  | (3,500 | ) |  | $ | 13.60 |  |  |  |  |
Outstanding and exercisable at September 30, 2022 |  |  | 499,933 |  |  | $ | 11.02 |  |  |  | 4.31 |
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY | Activity in RSUs during the three months ended September 30, 2023 and related balances outstanding as of that date are reflected below: SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY
|  | Number of Shares |  |  | Weighted Average Grant date Fair Value |  |  | Weighted Average Remaining Contract Term (# years) |
Outstanding at June 30, 2023 |  |  | 193,749 |  |  | $ | 6.09 |  |  |  |  |
Granted |  |  | - |  |  | $ | - |  |  |  |  |
Vested and settled |  |  | - |  |  | $ | - |  |  |  |  |
Forfeited and cancelled |  |  | (1,539 | ) |  | $ | 5.75 |  |  |  |  |
Outstanding at September 30, 2023 |  |  | 192,210 |  |  | $ | 6.09 |  |  |  | 0.74 |
Activity in RSUs during the three months ended September 30, 2022 and related balances outstanding as of that date are reflected below:
|  | Number of Shares |  |  | Weighted Average Grant date Fair Value |  |  | Weighted Average Remaining Contract Term (# years) |
Outstanding at June 30, 2022 |  |  | 304,221 |  |  | $ | 6.06 |  |  |  |  |
Granted |  |  | 5,034 |  |  | $ | 2.70 |  |  |  |  |
Vested and settled |  |  | (1,678 | ) |  | $ | 2.70 |  |  |  |  |
Forfeited and cancelled |  |  | (34,679 | ) |  | $ | 7.06 |  |  |  |  |
Outstanding at September 30, 2022 |  |  | 272,898 |  |  | $ | 5.89 |  |  |  | 1.53 |
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES | The following table summarizes stock-based compensation expense for employee and non-employee stock option and RSU grants: SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES
|  | Three Months Ended September 30, |
|  | 2023 |  |  | 2022 |
Research and development |  | $ | 60,000 |  |  | $ | 26,000 |
Selling and administrative |  |  | 216,000 |  |  |  | 69,000 |
Total stock-based compensation expense |  | $ | 276,000 |  |  | $ | 95,000 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration